Loading…
avatar for Stephen Friend

Stephen Friend

Sage Bionetworks
President
Dr. Friend is the President of Sage Bionetworks, a non-profit organization dedicated to redefining biomedical research through open systems, incentives and norms.  He is an authority in the field of cancer biology and a pioneer in the field of the genetics of gene expression integrating system biology approaches to complex diseases.  Under his leadership, Sage Bionetworks develops technology platforms for data-intensive analysis, governance platforms for data sharing and reuse, runs challenges to solve complex biomedical problems and performs cutting edge computational biology and research. Previously Dr. Friend was Senior Vice President and Franchise Head for Oncology Research at Merck & Co., Inc. where he led Merck’s Basic Cancer Research efforts.  Formerly Dr. Friend along with Dr. Hartwell founded and co-led the Fred Hutchinson Cancer Research Center’s “Seattle Project”, an advanced institute for drug discovery and later they co-founded Rosetta Inpharmatics with Dr. Leroy Hood. Dr. Friend also held faculty positions at Harvard Medical School from 1987 to 1995 and at Massachusetts General Hospital from 1990 to 1995. He received his M.D/Ph.D. from Indiana University.